NEW YORK (GenomeWeb) – Plant genome engineering firm Calyxt yesterday announced it has signed an exclusive license agreement with the University of Minnesota for worldwide rights to intellectual property for gene targeting.

Calyxt now has rights to a family of patents entitled "Gene Targeting in Plants Using DNA Viruses." The technology is based on a group of DNA viruses known as geminiviruses and enables efficient targeted modification of plant genomes in conjunction with customizable endonucleases, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.